Some of the effects of vaccination mentioned in section 4 (Possible side effects) may temporarily affect your ability to use machines or undertake activities such as cycling. While information on effects on pregnancy or the newborn baby after vaccination during the first trimester is limited, no change to the risk for miscarriage has been seen.Ĭomirnaty can be given during breastfeeding. A large amount of information from pregnant women vaccinated with Comirnaty during the second and third trimester have not shown negative effects on the pregnancy or the newborn baby. If your child is pregnant, tell your doctor, nurse or pharmacist before your child receives this vaccine.Ĭomirnaty can be used during pregnancy. Tell your doctor or pharmacist if your child is using, has recently used or might use any other medicines or has recently received any other vaccine. ChildrenĬomirnaty is not recommended for children aged under 5 years. Discuss appropriate individual recommendations with your doctor. In addition, your close contacts should be vaccinated as appropriate. In these cases, you should continue to maintain physical precautions to help prevent COVID-19. The efficacy of Comirnaty, even after a third dose, may be lower in people who are immunocompromised. Your child may receive a third dose of Comirnaty. Following vaccination, you should be alert to signs of myocarditis and pericarditis, such as breathlessness, palpitations and chest pain, and seek immediate medical attention should these occur.Īs with any vaccine, Comirnaty may not fully protect all those who receive it and it is not known how long you will be protected. They have been observed more often after the second vaccination, and more often in younger males. These conditions can develop within just a few days after vaccination and have primarily occurred within 14 days. There is an increased risk of myocarditis (inflammation of the heart muscle) and pericarditis (inflammation of the lining outside the heart) after vaccination with Comirnaty (see section 4). has a weakened immune system, because of a disease such as HIV infection or a medicine such as corticosteroid that affects the immune system. has a bleeding problem, bruises easily or uses a medicine to prevent blood-clots.However, your child can have the vaccination if he/she have a mild fever or upper airway infection like a cold. has a severe illness or infection with high fever.is feeling nervous about the vaccination process or has ever fainted following any needle injection.has ever had a severe allergic reaction or breathing problems after any other vaccine injection or after having been given Comirnaty in the past.Talk to your doctor, pharmacist or nurse before your child is given the vaccine if your child: if your child is allergic to the active substance or any of the other ingredients of this medicine (listed in section 6).2.What you need to know before your child receives Comirnaty Comirnaty should not be given The vaccine causes the immune system (the body’s natural defences) to produce antibodies and blood cells that work against the virus, so giving protection against COVID-19.Īs Comirnaty does not contain the virus to produce immunity, it cannot give your child COVID-19. Contents of the pack and other informationġ.What Comirnaty is and what it is used forĬomirnaty is a vaccine used for preventing COVID-19 caused by SARS-CoV-2 virus.Ĭomirnaty 10 micrograms/dose concentrate for dispersion for injection is given to children from 5 to 11 years of age.What you need to know before your child receives Comirnaty.What Comirnaty is and what it is used for.This includes any possible side effects not listed in this leaflet. If your child gets any side effects, talk to your doctor, pharmacist or nurse.If you have any further questions, ask your doctor, pharmacist or nurse.Read all of this leaflet carefully before you receive this vaccine because it contains important information for you. See the end of section 4 for how to report side effects. You can help by reporting any side effects your child may get. This will allow quick identification of new safety information. This medicine is subject to additional monitoring. Comirnaty 10 micrograms/dose concentrate for dispersion for injection, Children 5 to 11 years, COVID-19 mRNA Vaccine (nucleoside modified) tozinameran The patient leaflet for ages 12+ can be found here. This information is for the formulation of the COVID-19 Vaccine Pfizer/BioNTech for individuals aged 5-11 years old.
0 Comments
Leave a Reply. |